https://www.selleckchem.com/products/sbi-115.html
Administration of antithrombotic agents in neuroendovascular therapy is important to prevent periprocedural thromboembolic complications. Both anticoagulants that prevent red thrombi formed by flow stagnation in the catheter and antiplatelets that prevent white thrombi triggered by the implanted foreign body, such as coils and stents, are needed. With the progress of endovascular techniques and development of new devices, periprocedural antiplatelet therapy has been used more aggressively in recent years. Currently, the standard antipla
Like
Comment
Share
